• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中PI3K信号通路的基因改变

Genetic alterations in the PI3K pathway in prostate cancer.

作者信息

Sun Xiuju, Huang Jian, Homma Taku, Kita Daisuke, Klocker Helmut, Schafer Georg, Boyle Peter, Ohgaki Hiroko

机构信息

International Agency for Research on Cancer, Lyon, France.

出版信息

Anticancer Res. 2009 May;29(5):1739-43.

PMID:19443396
Abstract

Alterations in the PIK3CA and PTEN genes were assessed in 40 prostate tumors (radical prostatectomy samples). Genetic analyses in glands of the highest Gleason pattern within each tumor revealed PIK3CA amplification in 13%, PIK3CA mutations in 3%, PTEN homozygous deletion in 13% and PTEN hemizygous deletion in 8% of the cases analyzed. Supporting the view that PTEN and PIK3CA act in the same PI3K signaling pathway, genetic alterations in the PIK3CA and PTEN genes were mutually exclusive, except in one tumor. Overall, 13 of the 40 (33%) prostate tumors had alterations in the PI3K pathway. For cases with genetic alterations, other tumor areas with lower Gleason patterns as well as non-tumorous prostate glands were also analyzed. Of nine tumors with Gleason score 7, five cases contained the same genetic alterations in tumor areas of Gleason patterns 3 and 4, whereas in another four cases, genetic alterations were detected only in tumor areas of Gleason 4 but not Gleason 3 patterns. There were no alterations in non-tumorous glands. These results suggest that genetic alterations in the PI3K pathway are common in prostate cancer, and occur mainly through PIK3CA amplification and PTEN hemizygous or homozygous deletion. Glands of Gleason pattern 3 are genetically heterogeneous, some containing the same genetic alterations observed in glands of Gleason pattern 4.

摘要

在40例前列腺肿瘤(根治性前列腺切除术样本)中评估了PIK3CA和PTEN基因的改变。对每个肿瘤中Gleason分级最高的腺体进行基因分析,结果显示,在分析的病例中,13%存在PIK3CA扩增,3%存在PIK3CA突变,13%存在PTEN纯合缺失,8%存在PTEN半合子缺失。支持PTEN和PIK3CA在同一PI3K信号通路中起作用这一观点的是,PIK3CA和PTEN基因的基因改变相互排斥,但有一个肿瘤除外。总体而言,40例前列腺肿瘤中有13例(33%)PI3K通路存在改变。对于有基因改变的病例,还分析了其他Gleason分级较低的肿瘤区域以及非肿瘤性前列腺腺体。在9例Gleason评分为7的肿瘤中,5例在Gleason分级为3和4的肿瘤区域存在相同的基因改变,而在另外4例中,仅在Gleason分级为4的肿瘤区域检测到基因改变,而在Gleason分级为3的区域未检测到。非肿瘤性腺体未发现改变。这些结果表明,PI3K通路的基因改变在前列腺癌中很常见,主要通过PIK3CA扩增以及PTEN半合子或纯合子缺失发生。Gleason分级为3的腺体在基因上是异质性的,一些含有与Gleason分级为4的腺体中观察到的相同基因改变。

相似文献

1
Genetic alterations in the PI3K pathway in prostate cancer.前列腺癌中PI3K信号通路的基因改变
Anticancer Res. 2009 May;29(5):1739-43.
2
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中PIK3CA基因的致癌突变。
Int J Oncol. 2008 Jan;32(1):101-11.
3
PIK3CA mutations in glioblastoma multiforme.多形性胶质母细胞瘤中的PIK3CA突变
Acta Neuropathol. 2005 Jun;109(6):639-42. doi: 10.1007/s00401-005-1000-1. Epub 2005 May 28.
4
PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.子宫内膜样腺癌和复杂性非典型增生中的PIK3CA和PTEN突变
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5932-5. doi: 10.1158/1078-0432.CCR-06-1375.
5
PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney.转移性至肾脏的乳腺腺样囊性癌中的PIK3CA和PTEN突变
Hum Pathol. 2007 Sep;38(9):1425-31. doi: 10.1016/j.humpath.2007.03.021. Epub 2007 Jul 31.
6
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.中东人群中携带PIK3CA突变的结直肠癌的临床病理分析
Oncogene. 2008 Jun 5;27(25):3539-45. doi: 10.1038/sj.onc.1211013. Epub 2008 Jan 14.
7
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.儿童和成人多形性胶质母细胞瘤中的PIK3CA基因突变
Mol Cancer Res. 2006 Oct;4(10):709-14. doi: 10.1158/1541-7786.MCR-06-0172.
8
Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors.垂体肿瘤中PIK3CA基因的频繁突变和扩增。
Endocr Relat Cancer. 2009 Mar;16(1):301-10. doi: 10.1677/ERC-08-0167. Epub 2008 Oct 13.
9
In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.肿瘤抑制因子PTEN对过度活跃的磷脂酰肌醇3激酶p110催化癌蛋白平衡的体内功能分析
Cancer Res. 2007 Oct 15;67(20):9731-9. doi: 10.1158/0008-5472.CAN-07-1278.
10
A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.前列腺癌中磷脂酰肌醇-3激酶/蛋白激酶B信号转导通路转录特征的综合分析
BJU Int. 2008 Jun;101(11):1454-60. doi: 10.1111/j.1464-410X.2008.07540.x. Epub 2008 Mar 11.

引用本文的文献

1
Mucin-producing urothelial-type adenocarcinoma of the prostate with a gene mutation characteristic of intestinal adenocarcinoma: case report and literature review.具有肠道腺癌基因突变特征的前列腺黏液分泌性尿路上皮型腺癌:病例报告及文献复习
Front Med (Lausanne). 2025 Jan 20;11:1494952. doi: 10.3389/fmed.2024.1494952. eCollection 2024.
2
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.血清 CEA 升高与去势抵抗性前列腺癌患者的肝转移和独特的循环肿瘤 DNA 改变相关。
Prostate. 2022 Sep;82(13):1264-1272. doi: 10.1002/pros.24400. Epub 2022 Jun 29.
3
Prostate Cancer-Focus on Cholesterol.
前列腺癌——聚焦胆固醇
Cancers (Basel). 2021 Sep 19;13(18):4696. doi: 10.3390/cancers13184696.
4
TP53, SPOP and PIK3CA Genes Status in Prostate Cancer.TP53、SPOP 和 PIK3CA 基因在前列腺癌中的状态。
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3365-3371. doi: 10.31557/APJCP.2020.21.11.3365.
5
CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma.在头颈部鳞状细胞癌的临床前模型中,CDK 4/6抑制克服了对PI3Kα抑制的获得性和固有抗性。
J Clin Med. 2020 Oct 7;9(10):3214. doi: 10.3390/jcm9103214.
6
Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.姜黄素对雄激素依赖性和非依赖性前列腺癌抗癌活性的作用机制。
Nutrients. 2020 Mar 2;12(3):679. doi: 10.3390/nu12030679.
7
The Secret Life of Translation Initiation in Prostate Cancer.前列腺癌中翻译起始的隐秘机制
Front Genet. 2019 Jan 30;10:14. doi: 10.3389/fgene.2019.00014. eCollection 2019.
8
A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer.一项对头颈部癌中PIK3CA突变进行无创追踪的初步研究。
Diagnostics (Basel). 2018 Nov 29;8(4):79. doi: 10.3390/diagnostics8040079.
9
Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.蛋白激酶Cε通过CXCL13-CXCR5途径与PTEN缺失协同作用促进前列腺肿瘤发生。
Cell Rep. 2017 Apr 11;19(2):375-388. doi: 10.1016/j.celrep.2017.03.042.
10
Oncolytic virotherapy for urological cancers.溶瘤病毒治疗泌尿系统癌症。
Nat Rev Urol. 2016 Jun;13(6):334-52. doi: 10.1038/nrurol.2016.84. Epub 2016 May 24.